Suchergebnisse - "Greig, Nigel H"

PubPharm (621)

91

3,6'-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation

enthalten in: eLife | 2020

von Lin, C. | Lecca, D. | Yang, L. | +10

92

(-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury

enthalten in: CNS neuroscience & therapeutics | 2020

von Greig, N. | Lecca, D. | Hsueh, S. | +7

93

Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease

enthalten in: Expert opinion on investigational drugs | 2020

von Glotfelty, E. | Olson, L. | Karlsson, T. | +2

94

Correction : Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease

enthalten in: Translational psychiatry | 2020

von Ray, B. | Maloney, B. | Sambamurti, K. | +4

ErratumFor: Transl Psychiatry. 2020 Feb 3;10(1):47. - PMID 32066688

95

The p53 inactivators pifithrin-μ and pifithrin-α mitigate TBI-induced neuronal damage through regulation of oxidative stress, neuroinflammation, autophagy and mitophagy

enthalten in: Experimental neurology | 2020

von Yang, L. | Greig, N. | Tweedie, D. | +6

96

Traumatic brain injury increases plasma astrocyte-derived exosome levels of neurotoxic complement proteins

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2020

von Goetzl, E. | Yaffe, K. | Peltz, C. | +8

97

Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke Brain

enthalten in: iScience | 2020

von Yu, S. | Wu, K. | Bae, E. | +6

98

Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury

enthalten in: Experimental neurology | 2020

von Li, Y. | Glotfelty, E. | Namdar, I. | +6

99

METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM

enthalten in: Europäisches Patentamt | 2020

von KIM DONG SEOK | KIM HEE KYUNG | GREIG NIGEL H

100

Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease

enthalten in: Translational psychiatry | 2020

von Ray, B. | Maloney, B. | Sambamurti, K. | +4

ErratumIn: Transl Psychiatry. 2020 Mar 2;10(1):81. - PMID 32123156